Pre-opening Celebration of the Friese Family Tower at Providence Cedars-Sinai Tarzana Medical Center

Last year, Providence Alaska provided a $30,000 community investment grant to the Alaska Native Heritage Center to help enhance the lives of Alaska Native Elders.

A doctor at Providence St. Vincent Medical Center is the first in the world to perform a new and life-changing procedure.

Providence medical breast oncologist to give a special presentation on Lobular Breast Cancer and the latest data on the development of a lobular prevention vaccine.

If you’ve been diagnosed with high blood pressure, there are lots of ways you can lower your blood pressure without prescription medications.

Providence Alaska is excited to introduce its newest state-of-the-art mobile mammography coach, equipped to bring advanced breast cancer detection technology directly to communities.

Join us for a spooktacular time at our eighth annual Trunk or Treat on Friday, Oct. 24 from 3-5 p.m. for games, face painting, and more.

Providence Queen of the Valley Medical Center recently received a 4-star rating (out of 5 stars) from the Centers for Medicare and Medicaid Services (CMS).

The Disney Family Cancer Center in Burbank will be illuminated in pink throughout October to raise awareness about breast cancer and emphasize the importance of early detection and treatment.

Long before Providence Health & Services acquired Tarzana Hospital in 2008, the Baca family has been devoted to delivering compassionate care to the San Fernando Valley community.

Nourish Food Pantry receives $5,000 to provide nutritious food to cancer patients.

A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.

Two new trials evaluating new medications or combinations of medications for people with ovarian cancer or small cell lung cancer open at Providence Cancer Institute.

Providence Alaska Medical Center (PAMC) has received reaccreditation as a Bariatric Center of Excellence through the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program.

A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people with advanced cancers.

A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.

This is an exciting new trial comparing robotic assisted laparoscopy to open hysterectomy and lymph node assessment for the treatment of early-stage cervical cancer.

Two studies for people with ER+/HER2- breast cancer are enrolling patients at Providence Cancer Institute.